HomePAR • ASX
add
Paradigm Biopharmaceuticals Ltd
Previous close
$0.45
Day range
$0.44 - $0.47
Year range
$0.20 - $0.66
Market cap
190.58M AUD
Avg Volume
1.44M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
CNBC
3 hours ago
Stock futures are little changed ahead of highly awaited inflation data: Live updates
2.28%
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | -8.35K | — |
Operating expense | 8.49M | 13.50% |
Net income | -6.42M | -47.47% |
Net profit margin | 76.93K | — |
Earnings per share | — | — |
EBITDA | -8.46M | -13.58% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 16.82M | -5.87% |
Total assets | 24.57M | -13.40% |
Total liabilities | 3.39M | -5.49% |
Total equity | 21.18M | — |
Shares outstanding | 397.43M | — |
Price to book | 8.90 | — |
Return on assets | -86.45% | — |
Return on capital | -100.25% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -6.42M | -47.47% |
Cash from operations | -3.89M | 47.90% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | -62.10K | 1.06% |
Net change in cash | -3.98M | 49.40% |
Free cash flow | -5.25M | -17.86% |
About
Founded
2014
Website
